| 0023-1145 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-1145 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Sportpharm LLC |
| 0023-1145-01 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-1145-02 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3919 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3919-50 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3919-51 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3921 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3921-02 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-3921-03 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-9232 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-9232-01 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0023-9232-02 | These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. |
| 0259-1605 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1605-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1610 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1610-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1620 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1620-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-1620-10 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-4110 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-4110-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-4150 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0259-4150-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC |
| 0299-5962 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: April 2009 | Galderma Laboratories, L.P. | IPSEN BIOPHARM LTD |
| 0299-5962-01 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: April 2009 | Galderma Laboratories, L.P. | IPSEN BIOPHARM LTD |
| 0299-5962-30 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: April 2009 | Galderma Laboratories, L.P. | IPSEN BIOPHARM LTD |
| 15054-0500 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 15054-0500-1 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 15054-0500-2 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 15054-0500-9 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 15054-0530 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 15054-0530-6 | These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD |
| 43742-0015 | Drug Facts: | Deseret Biologicals, Inc. | Apotheca Company |
| 43742-0015-1 | Drug Facts: | Deseret Biologicals, Inc. | Apotheca Company |
| 43742-1421 | Drug Facts: | Deseret Biologicals, Inc. | Apotheca Company |
| 43742-1421-1 | Drug Facts: | Deseret Biologicals, Inc. | Apotheca Company |
| 43742-2021 | DRUG FACTS: | Deseret Biologicals, Inc. | Apotheca Company |
| 43742-2021-1 | DRUG FACTS: | Deseret Biologicals, Inc. | Apotheca Company |
| 43772-0003 | Drug Facts: | Synergy Formulas, Inc. | Apotheca Company |
| 43772-0003-1 | Drug Facts: | Synergy Formulas, Inc. | Apotheca Company |
| 43772-0020 | Drug Facts: | Synergy Formulas | Apotheca Company |
| 43772-0020-1 | Drug Facts: | Synergy Formulas | Apotheca Company |
| 43857-0464 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0464-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0523 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0523-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0576 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0576-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0582 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0582-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0632 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0632-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0634 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0634-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0639 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0639-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0655 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 43857-0655-1 | DRUG FACTS: | BioActive Nutritional, Inc. | Apotheca Company |
| 44911-0269 | DRUG FACTS: | Energique, Inc. | Apotheca Company |
| 44911-0269-1 | DRUG FACTS: | Energique, Inc. | Apotheca Company |
| 46783-160 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-160-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-160-10 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-161 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-161-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-165 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 46783-165-01 | These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. |
| 57520-0349 | Colosode | Apotheca Company |
| 57520-0349-1 | Colosode | Apotheca Company |
| 72301-595 | These highlights do not include all the information needed to use JEUVEAU ® safely and effectively. See full prescribing information for JEUVEAU . JEUVEAU (prabotulinumtoxinA-xvfs) for injection, for intramuscular use Initial U.S. Approval: 2019 | Evolus, Inc. |
| 72301-595-10 | These highlights do not include all the information needed to use JEUVEAU ® safely and effectively. See full prescribing information for JEUVEAU . JEUVEAU (prabotulinumtoxinA-xvfs) for injection, for intramuscular use Initial U.S. Approval: 2019 | Evolus, Inc. |
| 72960-112 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC |
| 72960-112-01 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC |
| 72960-112-02 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC |
| 72960-112-05 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC |
| 72960-112-06 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC |
| 84302-002 | ANTI-AGING SERUM | Shenzhen Hanchuan e-commerce Co., Ltd |
| 84302-002-01 | ANTI-AGING SERUM | Shenzhen Hanchuan e-commerce Co., Ltd |
| 85766-155 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Sportpharm LLC |
| 85766-155-01 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Sportpharm LLC |
| 85766-155-02 | These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Sportpharm LLC |